Anti-Herpes Zoster Vaccination of Fragile Patients in Hospital Setting: A Nudge Intervention in Italy
Abstract
:1. Introduction
2. Materials and Methods
2.1. Setting Procedure
- (a)
- Involvement of the specific operating units to identify frail patients to whom the vaccination campaign was targeted;
- (b)
- Training and information of health personnel in order to plan the operational strategy;
- (c)
- Planning and implementation of a traveling vaccination within the hospital setting that would directly reach the patient during the first visit or follow-up. This vaccine involves the administration of two doses (the second dose can be administered between 2 and 6 months after the first dose);
- (d)
- Patient involvement with specific vaccination information;
- (e)
- Vaccination and administration of a questionnaire.
2.2. Participants
2.3. Tools
- (1)
- Individual data, including demographic information, education level, presence of pathologies, previous other vaccinations, sources of information about HZ vaccines, public sentiments that influence vaccination behavior and health information levels of state, informed consent form and privacy policy, vaccine information (injection site, lot number, expiration date, route of administration, and health professional data). Enrolled subjects, when taking their first vaccine dose, were asked to anonymously fill out a purpose-built questionnaire and enter it on the Google Forms platform via a QRCode. All participants were made aware, through informed consent, that participation was voluntary and anonymous, that they could withdraw their consent at any time as well as of the use of data in anonymous and aggregate form.
- (2)
- Standardized tests: EuroQol-5D (EQ-5D); Perceived Stress Scale 10 (PSS-10); Multidimensional Scale of Perceived Social Support (MSPSS); and finally, a scale created ad hoc to detect perceptions, information, and beliefs about the virus and vaccine:
- -
- EQ-5D (EuroQol-5D) [55] is a standardized questionnaire used to measure health-related quality of life (HRQL). The instrument is divided into two sections; the first section (5 items) involves a subjective assessment of five dimensions: mobility, self-care, activities of daily living, pain/concern, and anxiety/depression. Each item involves responses from 1 to 3 (1 = no problem; 3 = extreme limitation). The second section includes an assessment by visual analog (VAS) graphically represented by a graded scale ranging from 0 to 100, on which the subject must indicate his or her perceived level of health (0 = worst possible health status; 100 = best possible health status);
- -
- PSS-10 (Perceived Stress Scale 10) [56] assesses individual perception with respect to particular everyday life situations and reactions in response to these stressful events. The respondent is asked to indicate how often he or she has felt or thought a certain way during the previous 4 weeks. The questionnaire consists of 10 items and involves responses rated on a 5-point Likert scale according to severity. Individual scores on the PSS can range from 0 to 40, with higher scores indicating a greater perception of stress;
- -
- MSPSS (Multidimensional Scale of Perceived Social Support) [57] is an instrument traditionally used to detect social support as a multidimensional construct. It consists of 12 items grouped into three factors: family, friends, and significant others. The respondent is asked to express his or her level of agreement on a 7-point Likert scale (1 = completely disagree; 7 = completely agree). The instrument allows for both a total score indicating the subjective assessment of the adequacy of perceived social support and a relative score for each subscale, ranging from 1 to 7, with higher scores indicating greater perceived social support. Previous studies have indicated that the MSPSS is a valid and reliable instrument for measuring the perception of social support in people with chronic illness [58];
- -
- A scale was created ad hoc to survey perceptions, information, and beliefs about the virus and vaccine. The scale consists of 16 items, with each item predicting responses from 1 to 4 (4 = totally agree; 1 = totally disagree). The scale has not been previously validated.
2.4. Statistical Analysis
3. Results
3.1. Sample Description
Public Sentiments That Influence Vaccination Behavior and Health Information Levels of State
3.2. Perceived Psychological Well-Being
- (a)
- Perception of general health status (VAS): a mean score of 71.96 (SD = 17.57), a score that is between the 25th and 50th percentile, as well as the EQ5-D index. The EQ5-D score is a summary of the five areas and is 0.79 (SD = 0.24).
- (b)
- Perceived Stress Scale (PSS10): Patients respond with a mean score of 13.87 (SD = 5.96). This score is in a border zone between low and medium perceived stress.
- (c)
- Perceived Social Support Scale (MSPSS): People are in the high social support range (mean = 65.37; SD = 16.19). Within the subscales, the score with the highest mean is defined by perceived family social support (Table 4).
3.3. Perception, Information, and Beliefs about the Virus and Vaccine
- Factor 1: confidence in collective knowledge and collective responsibility;
- Factor 2: beliefs about virus risk and vaccine function (social norm);
- Factor 3: information about the virus and symptomatology;
- Factor 4: vaccine distrust.
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- James, S.F.; Chahine, E.B.; Sucher, A.J.; Hanna, C. Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine. Ann. Pharmacother. 2018, 52, 673–680. [Google Scholar] [CrossRef] [PubMed]
- Patil, A.; Goldust, M.; Wollina, U. Herpes Zoster: A Review of Clinical Manifestations and Management. Viruses 2022, 14, 192. [Google Scholar] [CrossRef] [PubMed]
- Torcel-Pagnon, L.; Bricout, H.; Bertrand, I.; Perinetti, E.; Franco, E.; Gabutti, G.; Volpi, A. Impact of Underlying Conditions on Zoster-Related Pain and on Quality of Life Following Zoster. J. Gerontol. Ser. A Biomed. Sci. Med. Sci. 2017, 72, 1091–1097. [Google Scholar] [CrossRef] [PubMed]
- Devraj, R.; Wilhelm, M.; Deshpande, M. Consumer Perceptions of a Shingles Infograph Intervention and Vaccination Plans in Community Pharmacy Settings. Innov. Pharm. 2022, 13, 1. [Google Scholar] [CrossRef]
- Bricout, H.; Haugh, M.; Olatunde, O.; Gil Prieto, R. Herpes Zoster-Associated Mortality in Europe: A Systematic Review. BMC Public Health 2015, 15, 466. [Google Scholar] [CrossRef] [PubMed]
- Alexander, K.E.; Tong, P.L.; Macartney, K.; Beresford, R.; Sheppeard, V.; Gupta, M. Live zoster vaccination in an immunocompromised patient leading to death secondary to disseminated varicella zoster virus infection. Vaccine 2018, 36, 3890–3893. [Google Scholar] [CrossRef] [PubMed]
- Maltz, F.; Fidler, B. Shingrix: A New Herpes Zoster Vaccine. Pharm. Ther. 2019, 44, 406–433. [Google Scholar]
- MacDonald, N.E. Vaccine Hesitancy: Definition, Scope and Determinants. Vaccine 2015, 33, 4161–4164. [Google Scholar] [CrossRef]
- Savarese, G.; Carpinelli, L.; De Chiara, A.; Giordano, C.; Perillo, M.; Fornino, D.; De Caro, F.; Capunzo, M.; Moccia, G. Anti-SARS-CoV-2 Vaccination Campaign: Risk Perception, Emotional States, and Vaccine Hesitancy in a Sample of Adolescents’ Vaccinated Parents in Southern Italy. Vaccines 2022, 10, 958. [Google Scholar] [CrossRef]
- Moccia, G.; Carpinelli, L.; Savarese, G.; De Caro, F. Vaccine Hesitancy and the Green Digital Pass: A Study on Adherence to the Italian COVID-19 Vaccination Campaign. Int. J. Environ. Res. Public Health 2022, 19, 2970. [Google Scholar] [CrossRef]
- Gobo, G.; Sena, B. Questioning and disputing vaccination policies. Scientists and experts in the Italian public debate. Bull. Sci. Technol. Soc. 2022, 42, 25–38. [Google Scholar] [CrossRef]
- World Health Organization. How to Implement Seasonal Flu Vaccination of Health Workers: An Introduction Manual for National Immunization Programme Managers and Policy Makers: Pilot Version 2019; World Health Organization: Geneva, Switzerland, 2019. [Google Scholar]
- Barbaroux, A.; Benoit, L.; Raymondie, R.A.; Milhabet, I. Nudging health care workers towards a flu shot: Reminders are accepted but not necessarily effective. A randomized controlled study among residents in general practice in France. Fam. Pract. 2021, 38, 410–415. [Google Scholar] [CrossRef] [PubMed]
- Felsen, G.; Castelo, N.; Reiner, P.B. Decisional enhancement and autonomy: Public attitudes towards overt and covert nudges. Judgm. Decis. Mak. 2013, 8, 202–213. [Google Scholar] [CrossRef]
- Reñosa, M.D.C.; Landicho, J.; Wachinger, J.; Dalglish, S.L.; Bärnighausen, K.; Bärnighausen, T.; McMahon, S.A. Nudging toward vaccination: A systematic review. BMJ Glob. Health 2021, 6, e006237. [Google Scholar] [CrossRef] [PubMed]
- Gatwood, J.; Brookhart, A.; Kinney, O.; Hagemann, T.; Chiu, C.Y.; Ramachandran, S.; Gravlee, E.; Hohmeier, K. Impact of patient and provider nudges on addressing herpes zoster vaccine series completion. Vaccine 2023, 41, 778–786. [Google Scholar] [CrossRef] [PubMed]
- Jensen, U.T.; Ayers, S.; Koskan, A.M. Video-based messages to reduce COVID-19 vaccine hesitancy and nudge vaccination intentions. PLoS ONE 2022, 17, e0265736. [Google Scholar] [CrossRef] [PubMed]
- Schmidt, A.T.; Engelen, B. The ethics of nudging: An overview. Philos. Compass 2020, 15, e12658. [Google Scholar] [CrossRef]
- Thaler, R.H.; Sunstein, C.R. Nudge: Improving Decisions about Health, Wealth, and Happiness; Yale University Press: New Heaven, CT, USA, 2008. [Google Scholar]
- Brewer, N.T.; Chapman, G.B.; Rothman, A.J.; Leask, J.; Kempe, A. Increasing Vaccination: Putting Psychological Science into Action. Psychol. Sci. Public Interest 2017, 18, 149–207. [Google Scholar] [CrossRef] [PubMed]
- Ceccarelli, A.; Tamarri, F.; Angelini, R.; Bakken, E.; Concari, I.; Giannoccaro, E.; Domeniconi, G.; Morri, M.; Reali, C.; Righi, F.; et al. Herpes Zoster Vaccine Uptake and Active Campaign Impact, a Multicenter Retrospective Study in Italy. Vaccines 2024, 12, 51. [Google Scholar] [CrossRef]
- Volpi, A.; Boccalini, S.; Dari, S.; Clarke, C.; Curran, D.; Loiacono, I.; Pitrelli, A.; Puggina, A.; Tosatto, R.; Van Oorschot, D.; et al. The Potential Public Health Impact of Herpes Zoster Vaccination in the 65 Years of Age Cohort in Italy. Hum. Vaccines Immunother. 2020, 16, 327–334. [Google Scholar] [CrossRef]
- Hofmann, W.; Friese, M.; Wiers, R.W. Impulsive versus Reflective Influences on Health Behavior: A Theoretical Framework and Empirical Review. Health Psychol. Rev. 2008, 2, 111–137. [Google Scholar] [CrossRef]
- Marteau, T.M.; Hollands, G.J.; Fletcher, P.C. Changing human behavior to prevent disease: The importance of targeting automatic processes. Science 2012, 337, 1492–1495. [Google Scholar] [CrossRef] [PubMed]
- Marteau, T.M.; Ogilvie, D.; Roland, M.; Suhrcke, M.; Kelly, M.P. Judging nudging: Can nudging improve population health? Br. Med. J. 2011, 342, d228. [Google Scholar] [CrossRef] [PubMed]
- Sheeran, P.; Gollwitzer, P.M.; Bargh, J.A. Nonconscious processes and health. Health Psychol. 2013, 32, 460–473. [Google Scholar] [CrossRef] [PubMed]
- Strack, F.; Deutsch, R. Reflective and impulsive determinants of social behavior. Personal. Soc. Psychol. Rev. 2004, 8, 220–247. [Google Scholar] [CrossRef] [PubMed]
- Frey, E.; Rogers, T. Persistence: How treatment effects persist after interventions stop. Policy Insights Behav. Brain Sci. 2014, 1, 172–179. [Google Scholar] [CrossRef]
- Ariely, D.; Norton, M.I. How actions create not just reveal preferences. Trends Cogn. Sci. 2008, 12, 13–16. [Google Scholar] [CrossRef] [PubMed]
- Bem, D.J. Self-Perception Theory. In Advances in Experimental Social Psychology; Academic Press: New York, NY, USA; London, UK, 1972; Volume 6, pp. 1–62. [Google Scholar]
- Hertwig, R.; Grüne-Yanoff, T. Nudging and boosting: Steering or empowering good decisions. Perspect. Psychol. Sci. 2017, 12, 973–986. [Google Scholar] [CrossRef] [PubMed]
- Pecoraro, N.; Malatesta, F.; Carpinelli, L.; Fornino, D.; Giordano, C.; Moccia, G.; Perillo, M.; Capunzo, M.; Savarese, G.; De Caro, F. Individual and Contextual Determinants of Flu Vaccination Adherence: A University Nudge Intervention. Int. J. Environ. Res. Public Health 2023, 20, 5900. [Google Scholar] [CrossRef]
- Clark, N.M. Health educators and the future: Lead, follow, or get out of the way. Health Educ. Behav. 2014, 41, 492–498. [Google Scholar] [CrossRef]
- Ledderer, L.; Kjær, M.; Madsen, E.K.; Busch, J.; Fage-Butler, A. Nudging in Public Health Lifestyle Interventions: A Systematic Literature Review and Metasynthesis. Health Educ. Behav. 2020, 47, 749–764. [Google Scholar] [CrossRef]
- Ewert, B. Promoting health in schools: Theoretical reflections on the settings approach versus nudge tactics. Soc. Theory Health 2017, 15, 430–447. [Google Scholar] [CrossRef]
- Gatwood, J.; Brookhart, A.; Kinney, O.; Hagemann, T.; Chiu, C.Y.; Ramachandran, S.; Hohmeier, K.C. Clinical Nudge Impact on Herpes Zoster Vaccine Series Completion in Fharmacies. Am. J. Perceived Med. 2022, 63, 582–591. [Google Scholar] [CrossRef]
- Moccia, G.; Carpinelli, L.; Savarese, G.; Borrelli, A.; Boccia, G.; Motta, O.; Capunzo, M.; De Caro, F. Perception of Health, Mistrust, Anxiety, and Indecision in a Group of Italians Vaccinated against COVID-19. Vaccines 2021, 9, 612. [Google Scholar] [CrossRef] [PubMed]
- Carpinelli, L.; De Caro, F.; Savarese, G.; Oro, R.; Calabrese, M.C.; Pacifico, A.; Santoro, E.; Boccia, G.; Motta, O.; Capunzo, M.; et al. Perceived stress, coping strategies and emotions during the anti-COVID-19 vaccination among Italian university students of health professions. Psychol. Hub 2022, 39, 5–12. [Google Scholar] [CrossRef]
- Carpinelli, L.; De Caro, F.; Savarese, G.; Capunzo, M.; Mollo, M.; Moccia, G. Emotions and Motivations Underlying Adherence to the Anti-COVID-19 Vaccination Campaign: A Survey on a Sample of Italians under 30 Years. Int. J. Environ. Res. Public Health 2022, 19, 77. [Google Scholar] [CrossRef]
- Shuvo, S.; Hagemann, T.; Hohmeier, K.C.; Chiu, C.Y.; Ramachandran, S.; Gatwood, J. The role of social determinants in timely herpes zoster vaccination among older American adults. Hum. Vaccines Immunother. 2021, 17, 2043–2049. [Google Scholar] [CrossRef] [PubMed]
- La, E.M.; Trantham, L.; Kurosky, S.K.; Odom, D.; Aris, E.; Hogea, C. An analysis of factors associated with influenza, pneumoccocal, Tdap, and herpes zoster vaccine uptake in the US adult population and corresponding inter-state variability. Hum. Vaccines Immunother. 2018, 14, 430–441. [Google Scholar] [CrossRef]
- Reyna, V.F. Risk Perception and Communication in Vaccination Decisions: A Fuzzy-Trace Theory Approach. Vaccine 2012, 30, 3790–3797. [Google Scholar] [CrossRef]
- Betsch, C.; Schmid, P.; Heinemeier, D.; Korn, L.; Holtmann, C.; Böhm, R. Beyond Confidence: Development of a Measure Assessing the 5C Psychological Antecedents of Vaccination. PLoS ONE 2018, 13, e0208601. [Google Scholar] [CrossRef]
- Lorini, C.; Ierardi, F.; Gatteschi, C.; Galletti, G.; Collini, F.; Peracca, L.; Zanobini, P.; Gemmi, F.; Bonaccorsi, G. Promoting Influenza Vaccination among Staff of Nursing Homes According to Behavioral Insights: Analyzing the Choice Architecture during a Nudge-Based Intervention. Vaccines 2020, 8, 600. [Google Scholar] [CrossRef]
- Vogelsang, E.M.; Polonijo, A.N. Scarier than the Flu Shot?: The Social Determinants of Shingles and Influenza Vaccinations among U.S. Older Adults. Vaccine 2022, 40, 6747–6755. [Google Scholar] [CrossRef]
- Wang, Q.; Yang, L.; Li, L.; Liu, C.; Jin, H.; Lin, L. Willingness to Vaccinate Against Herpes Zoster and Its Associated Factors Across WHO Regions: Global Systematic Review and Meta-Analysis. JMIR Public Health Surveill. 2023, 9, e43893. [Google Scholar] [CrossRef] [PubMed]
- Deiana, C.; Geraci, A.; Mazzarella, G.; Sabatini, F. Perceived Risk and Vaccine Hesitancy: Quasi-experimental Evidence from Italy. Health Econ. 2022, 31, 1266–1275. [Google Scholar] [CrossRef]
- Benecke, O.; DeYoung, S.E. Anti-vaccine decision-making and measles resurgence in the United States. Glob. Pediatr. Health 2019, 6, 2333794X19862949. [Google Scholar] [CrossRef] [PubMed]
- Enyinnaya, J.C.; Anderson, A.A.; Kelp, N.C.; Long, M.; Duncan, C.G. The Social Ecology of Health Beliefs and Misinformation Framework: Examining the impact of misinformation on vaccine uptake through individual and sociological factors. Vaccine 2024, 42, 455–463. [Google Scholar] [CrossRef]
- Paoli, S.; Lorini, C.; Puggelli, F.; Sala, A.; Grazzini, M.; Paolini, D.; Bonanni, P.; Bonaccorsi, G. Assessing Vaccine Hesitancy among Healthcare Workers: A Cross-Sectional Study at an Italian Paediatric Hospital and the Development of a Healthcare Worker’s Vaccination Compliance Index. Vaccines 2019, 7, 201. [Google Scholar] [CrossRef] [PubMed]
- Datta, B.K.; Jaremski, J.E.; Ansa, B.E.; Odhiambo, L.A.; Islam, K.M.M.; Johnson, J.A. Role of Perceived Social Support in COVID-19 Vaccine Uptake among U.S. Adults. AJPM Focus 2023, 2, 100104. [Google Scholar] [CrossRef]
- Facciani, M.; Lazić, A.; Viggiano, G.; McKay, T. Political network composition predicts vaccination attitudes. Soc. Sci. Med. 2023, 328, 116004. [Google Scholar] [CrossRef]
- Santinello, M.; Vieno, A. Metodi di Intervento in Psicologia di Comunità; Il Mulino: Bologna, Italy, 2013. [Google Scholar]
- Bronfenbrenner, U. The Ecology of Human Development: Experiments by Nature and Design; Harvard University Press: Cambridge, MA, USA, 1979. [Google Scholar]
- Balestroni, G.; Bertolotti, G. EuroQol-5D (EQ-5D): An instrument for measuring quality of life. Monaldi Arch. Chest Dis. 2012, 78, 155–159. [Google Scholar] [CrossRef]
- Cohen, S.; Kamarck, T.; Mermelstein, R. A Global Measure of Perceived Stress. J. Health Soc. Behav. 1983, 24, 385. [Google Scholar] [CrossRef] [PubMed]
- Zimet, G.D.; Dahlem, N.W.; Zimet, S.G.; Farley, G.K. The Multidimensional Scale of Perceived Social Support. J. Personal. Assess. 1988, 52, 30–41. [Google Scholar] [CrossRef]
- Maria, M.; Vellone, E.; Durante, A.; Biagioli, V.; Matarese, M. Psychometric Evaluation of the Multidimensional Scale of Perceived Social Support (MSPSS) in People with Chronic Diseases. Ann. Dell’istituto Super. Sanità 2018, 54, 308–315. [Google Scholar] [CrossRef] [PubMed]
- Di Giuseppe, G.; Pelullo, C.P.; Napoli, A.; Napolitano, F. Willingness to receive Herpes Zoster vaccination among adults and older people: A cross-sectional study in Italy. Vaccine 2023, 41, 7244–7249. [Google Scholar] [CrossRef] [PubMed]
- Weijers, R.J.; de Koning, B.B.; Paas, F. Nudging in education: From theory towards guidelines for successful implementation. Eur. J. Psychol. Educ. 2021, 36, 883–902. [Google Scholar] [CrossRef]
- Bonanni, P.; Steffen, R.; Schelling, J.; Balaisyte-Jazone, L.; Posiuniene, I.; Zatoński, M.; Van Damme, P. Vaccine co-administration in adults: An effective way to improve vaccination coverage. Hum. Vaccines Immunother. 2023, 19, 2195786. [Google Scholar] [CrossRef] [PubMed]
- Carrieri, V.; Madio, L.; Principe, F. Vaccine Hesitancy and (Fake) News: Quasi-experimental Evidence from Italy. Health Econ. 2019, 28, 1377–1382. [Google Scholar] [CrossRef]
- Anolli, L. La Sfida Della Mente Multiculturale. Nuove Forme di Convivenza; Raffaello Cortina: Milano, Italy, 2011. [Google Scholar]
- Moccia, G.; De Caro, F.; Savarese, G.; De Chiara, A.; Giordano, C.; Perillo, M.; Fornino, D.; Capunzo, M.; Carpinelli, L. A Brief Report Monitoring the Different Emotional States Associated with the First and the Fourth Dose of the Anti-SARS-CoV-2 Vaccine in an Italian Sample of Fragile Patients Aged over 60 Years. Adv. Soc. Sci. Res. J. 2022, 9, 138–144. [Google Scholar] [CrossRef]
- Ceccarelli, A.; Scrimaglia, S.; Fossi, V.; Ceccaroni, L.; Federici, A.; Reali, C.; Angelini, R.; Silvestrini, G.; Sintoni, F.; Fantini, M.P.; et al. Adherence to Herpes Zoster (Shingles) Catch-Up Campaign at the Romagna Local Health Authority (Italy), a Multi-Center Retrospective Observational Study. Vaccines 2022, 10, 1770. [Google Scholar] [CrossRef]
Main Categories | Variables | % | |
---|---|---|---|
Socio-demographic | Gender | Men | 62.5% |
Women | 37.5% | ||
Work | Employee | 14.3% | |
Teacher | 4.2% | ||
Housewife | 11.9% | ||
Worker/Craftsman | 11.9% | ||
Self-employed | 10.7% | ||
Student | 2.4% | ||
Retiree | 28.6% | ||
Unemployed | 8.3% | ||
Other | 7.7% | ||
Marital status | Married | 67.9% | |
Separated/Divorced | 6.5% | ||
Single | 19.6% | ||
Widowed | 3.0% | ||
Cohabiting | 3.0% | ||
Live | Cohabiting with family or roommates | 89.9% | |
Live alone | 10.1% | ||
Level of schooling | Secondary school degree | 78.0% | |
University degree/Post-graduate training | 22.0% | ||
Vaccinations and Hz infection | HZ vaccination | First | 98.0% |
Second | 2.0% | ||
HZ infection | Yes | 24.4% | |
no | 75.6% |
Variable | Total Count% | |
---|---|---|
Previous pathologies | Chronic heart disease | 19.7% |
Hypertension | 62.8% | |
Diabetes mellitus | 20.1% | |
Lung diseases | 7.9% | |
Immunosuppressive therapy | 77.4% | |
Rheumatological diseases | 6.1% | |
Oncological pathologies | 6.1% | |
Dialysis treatment | 1.8% | |
Organ transplantation | 2.4% | |
Hematopoietic stem cell transplantation | 4.3% |
Item on Vaccination Campaign Information | % | |
---|---|---|
Sources used in the vaccination campaign | Media (TV-Radio) | 10.1% |
Web and social web | 14.3% | |
Doctors | 73.8% | |
Pass the word | 1.8% | |
Degree of satisfaction with sources | Totally dissatisfied | 9.1% |
Somewhat dissatisfied | 14.0% | |
Neither satisfied nor dissatisfied | 14.0% | |
Fairly satisfied | 27.4% | |
Satisfied | 32.3% | |
I have had no experience with this | 3.0% |
MPSS Scores Categories | Mean | SD |
---|---|---|
Family | 23.14 | 5.453 |
Friends | 19.81 | 6.737 |
Significant others | 22.42 | 6.145 |
Total score | 65.37 | 16.194 |
Item | Factors Extracted | |||
---|---|---|---|---|
I | II | III | IV | |
7. I believe that by vaccinating myself, I protect those close to me. | 0.596 | |||
13. I trust the progress of science in the field of vaccines and, in particular, Herpes Zoster. | 0.622 | |||
14. I trust the information I have received from healthcare personnel. | 0.816 | |||
16. I trust the information I received from my family members. | 0.613 | |||
2. I believe that Herpes Zoster is a serious disease. | 0.610 | |||
4. I believe the probability of contracting Herpes Zoster is high if I don’t get vaccinated. | 0.637 | |||
6. I believe that the vaccine can protect me in the future. | 0.493 | |||
8. I think everyone should get the Herpes Zoster vaccine. | 0.602 | |||
1. In general, I am sufficiently informed about the Herpes Zoster virus. | 0.650 | |||
2. I am sufficiently informed about the symptoms and consequences of Herpes Zoster. | 0.928 | |||
11. I am against vaccination. | 0.929 | |||
12. The fact that some vaccinations are not mandatory means that they are not necessary. | 0.686 | |||
% variance explained | 36.8 | 10.7 | 7.2 | 5.2 |
Variables | Factors | |||
---|---|---|---|---|
I | II | III | IV | |
Age | −0.163 * | 0.199 * | 0.046 | 0.087 |
EQ-5D (EQ index) | 0.094 | −0.118 | 0.110 | 0.032 |
EQ-5D (VAS) | 0.172 * | 0.133 * | 0.041 | −0.020 |
PSS10 stairs | −0.080 | 0.108 | −0.073 | 0.172 * |
MSPSS (total score) | 0.097 | −0.060 | 0.052 | −0.363 * |
MSPSS (family scale) | 0.091 | −0.035 | 0.021 | −0.348 * |
MSPSS (friends scale) | 0.141 | −0.058 | 0.048 | −0.267 * |
MPSS (significant other scale) | 0.020 | −0.065 | 0.064 | −0.355 * |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
De Caro, F.; Malatesta, F.; Pecoraro, N.; Capunzo, M.; Carpinelli, L.; Caruccio, S.; Cersosimo, G.; Costantino, M.; Giordano, C.; Longanella, W.; et al. Anti-Herpes Zoster Vaccination of Fragile Patients in Hospital Setting: A Nudge Intervention in Italy. Vaccines 2024, 12, 442. https://doi.org/10.3390/vaccines12040442
De Caro F, Malatesta F, Pecoraro N, Capunzo M, Carpinelli L, Caruccio S, Cersosimo G, Costantino M, Giordano C, Longanella W, et al. Anti-Herpes Zoster Vaccination of Fragile Patients in Hospital Setting: A Nudge Intervention in Italy. Vaccines. 2024; 12(4):442. https://doi.org/10.3390/vaccines12040442
Chicago/Turabian StyleDe Caro, Francesco, Francesca Malatesta, Nadia Pecoraro, Mario Capunzo, Luna Carpinelli, Simona Caruccio, Giuseppina Cersosimo, Maria Costantino, Claudio Giordano, Walter Longanella, and et al. 2024. "Anti-Herpes Zoster Vaccination of Fragile Patients in Hospital Setting: A Nudge Intervention in Italy" Vaccines 12, no. 4: 442. https://doi.org/10.3390/vaccines12040442
APA StyleDe Caro, F., Malatesta, F., Pecoraro, N., Capunzo, M., Carpinelli, L., Caruccio, S., Cersosimo, G., Costantino, M., Giordano, C., Longanella, W., Patella, V., Saggese Tozzi, A., Savarese, G., Sinopoli, P., Vozzella, E. A., & Moccia, G. (2024). Anti-Herpes Zoster Vaccination of Fragile Patients in Hospital Setting: A Nudge Intervention in Italy. Vaccines, 12(4), 442. https://doi.org/10.3390/vaccines12040442